NIH Notices

  • Request for Information (RFI): Inviting Comments on the Environmental Influences on Child Health Outcomes (ECHO)-wide Cohort Data Collection Protocol
    (NOT-OD-17-090) National Institutes of Health
  • Findings of Research Misconduct
    (NOT-OD-17-100) National Institutes of Health
  • Notice to Extend the Expiration Date for PA-14-190 “Epidemiology and Prevention in Alcohol Research (R01)”
    (NOT-AA-17-009)
    National Institute on Alcohol Abuse and Alcoholism
  • Notice to Extend the Expiration Date for PA-14-189 “Epidemiology and Prevention in Alcohol Research (R03)”
    (NOT-AA-17-010)
    National Institute on Alcohol Abuse and Alcoholism
  • Notice to Extend the Expiration Date for PA-14-188 “Epidemiology and Prevention in Alcohol Research (R21)”
    (NOT-AA-17-011)
    National Institute on Alcohol Abuse and Alcoholism
  • Notice of Clarification for Other Attachments in PAR-15-316 “Limited Competition for the Renewal of the National Cell Repository of Alzheimer’s Disease (NCRAD) (U24)”
    (NOT-AG-17-014)
    National Institute on Aging
  • Request for Information on Bioethics Issues in Cancer Research and Care
    (NOT-CA-17-079)
    National Cancer Institute
  • Notice of NCI’s participation on PAR-17-450 “Limited Competition: Lasker Clinical Research Scholars Transition Award (R00)”
    (NOT-CA-17-080)
    National Cancer Institute
  • Notice of NIDA’s Participation in PAR-17-257 “PsychENCODE: Non-coding Functional Elements in the Human Brain and their Role in the Development of Psychiatric Disorders (U01)”
    (NOT-DA-17-052)
    National Institute on Drug Abuse
    National Institute of Mental Health
  • Notice of Change to Expiration Date in NOT-DA-17-049 ” Request for Information (RFI): Patient and Family Needs and Requirements to be Addressed by the Small Business Programs of the National Institute on Drug Abuse (NIDA)”
    (NOT-DA-17-053)
    National Institute on Drug Abuse
  • Notice Of Change to RFA-ES-16-004 Maintain and Enrich Resource Infrastructure for Existing Environmental Epidemiology Cohorts (R24)
    (NOT-ES-17-007)
    National Institute of Environmental Health Sciences
  • Notice of Applicant Information Webinar for NHGRI IGNITE II RFAs: RFA-HG-17-008, RFA-HG-17-009 and RFA-HG-17-010
    (NOT-HG-17-014)
    National Human Genome Research Institute
  • Notice of Update to Omics Services included in PAR-16-021 “NHLBI TOPMed: Omics Phenotypes of Heart, Lung, and Blood Disorders (X01)”
    (NOT-HL-17-351)
    National Heart, Lung, and Blood Institute
  • AHRQ Announces Interest in Innovative Methods Research to Increase the Utility of Systematic Reviews
    (NOT-HS-17-019)
    Agency for Healthcare Research and Quality
  • Notice of NIMH’s Participation in PAR-17-438 “Assay development and screening for discovery of chemical probes or therapeutic agents (R01)”
    (NOT-MH-17-041)
    National Institute of Mental Health
  • Notice to Extend PA-14-172 “Novel Tools for Investigating Brain-derived GPCRs in Mental Health Research (R43/R44)”
    (NOT-MH-17-042)
    National Institute of Mental Health
  • Notice to Extend PA-14-171 “Novel Tools for Investigating Brain-derived GPCRs in Mental Health Research (R41/R42)”
    (NOT-MH-17-043)
    National Institute of Mental Health
  • Notice of NINR’s Participation on PAR-17-450 “Limited Competition: Lasker Clinical Research Scholars Transition Award (R00)”
    (NOT-NR-17-025)
    National Institute of Nursing Research
  • Notice of Informational Webinar for RFA-NS-17-024 “NINDS Clinical Research Sites for the Network of Excellence in Neuroscience Clinical Trials (NeuroNEXT sites) (U24)”
    (NOT-NS-17-039)
    National Institute of Neurological Disorders and Stroke
  • Notice of Extension of NINDS Faculty Development Award to Promote Diversity in Neuroscience Research (K01) to up to 5 Years of Support
    (NOT-NS-18-001)
    National Institute of Neurological Disorders and Stroke
  • NINDS Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) (R41, R42, R43, R44)
    (NOT-NS-18-002)
    National Institute of Neurological Disorders and Stroke
  • Notice of a Pre-Application Webinar for the Common Fund Metabolomics Program Stage 2 FOAs (RFA-RM-17-011, RFA-RM-17-012, RFA-RM-17-013, and RFA-RM-17-014)
    (NOT-RM-17-036)
    NIH Roadmap Initiatives
Advertisements
This entry was posted in Uncategorized. Bookmark the permalink.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s